Literature DB >> 18791331

Stereotactic biopsy in gliomas guided by 3-tesla 1H-chemical-shift imaging of choline.

Elvis J Hermann1, Elke Hattingen, Joachim K Krauss, Gerhard Marquardt, Ulrich Pilatus, Kea Franz, Matthias Setzer, Thomas Gasser, Dominique S Tews, Friedhelm E Zanella, Volker Seifert, Heinrich Lanfermann.   

Abstract

OBJECTIVE: To investigate chemical-shift imaging (CSI) to guide stereotactic biopsy of the choline 'hot spot' in cerebral lesions suggestive of low-grade glioma.
METHODS: Nine patients with hyperintense lesions on T(2)-weighted images of standard magnetic resonance imaging without contrast enhancement underwent advanced magnetic resonance studies. These studies included 3-dimensional T(1)-weighted sequences with contrast enhancement and 2-dimensional (1)H-CSI spectroscopy at 3 T. Signal intensity maps with relative signal intensities for choline were generated. The region with the highest choline signal intensity (the hot spot) was chosen as the target for stereotactic biopsy. The histopathological results were correlated with the increase in choline.
RESULTS: All spectroscopic data were of sufficient quality. In 5 instances the neuropathological diagnosis was grade II glioma, according to the WHO classification, and in 4 instances it was grade III glioma. According to the CSI criteria, all grade III gliomas and 4 of the 5 grade II gliomas were classified correctly. One grade II glioma was overestimated by CSI as a high-grade glioma.
CONCLUSION: (1)H-CSI-guided stereotactic biopsy may offer advantages as compared to conventional stereotactic biopsy. The biopsy of the choline hot spot in suggestive low-grade gliomas may help to identify focal points of higher tumor malignancy independent of contrast enhancement. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18791331     DOI: 10.1159/000155232

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  10 in total

1.  Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies.

Authors:  Georg Widhalm; Georgi Minchev; Adelheid Woehrer; Matthias Preusser; Barbara Kiesel; Julia Furtner; Aygül Mert; Antonio Di Ieva; Boguslaw Tomanek; Daniela Prayer; Christine Marosi; Johannes A Hainfellner; Engelbert Knosp; Stefan Wolfsberger
Journal:  Neurosurg Rev       Date:  2012-03-10       Impact factor: 3.042

Review 2.  Whole Brain ¹H-Spectroscopy: A Developing Technique for Advanced Analysis of Cerebral Metabolism.

Authors:  X-Q Ding; H Lanfermann
Journal:  Clin Neuroradiol       Date:  2015-07-09       Impact factor: 3.649

3.  Biopsy targeting with dynamic contrast-enhanced versus standard neuronavigation MRI in glioma: a prospective double-blinded evaluation of selection benefits.

Authors:  Vera C Keil; Bogdan Pintea; Gerrit H Gielen; Susanne Greschus; Rolf Fimmers; Jürgen Gieseke; Matthias Simon; Hans H Schild; Dariusch R Hadizadeh
Journal:  J Neurooncol       Date:  2017-04-19       Impact factor: 4.130

4.  Assessment of molecular markers demonstrates concordance between samples acquired via stereotactic biopsy and open craniotomy in both anaplastic astrocytomas and glioblastomas.

Authors:  Florian Gessler; Peter Baumgarten; Joshua D Bernstock; Patrick Harter; Stephanie Lescher; Christian Senft; Volker Seifert; Gerhard Marquardt; Lutz Weise
Journal:  J Neurooncol       Date:  2017-05-15       Impact factor: 4.130

Review 5.  [Clinical magnetic resonance imaging : Frequent incidental cerebral findings].

Authors:  A Müller; P Ditter; S Weidauer; H-H Schild; E Hattingen
Journal:  Radiologe       Date:  2017-04       Impact factor: 0.635

Review 6.  Imaging of brain tumors: MR spectroscopy and metabolic imaging.

Authors:  Alena Horská; Peter B Barker
Journal:  Neuroimaging Clin N Am       Date:  2010-08       Impact factor: 2.264

7.  Heterogeneity in malignant gliomas: a magnetic resonance analysis of spatial distribution of metabolite changes and regional blood volume.

Authors:  Marlies Wagner; Reinhold Nafe; Alina Jurcoane; Ulrich Pilatus; Kea Franz; Johannes Rieger; Joachim P Steinbach; Elke Hattingen
Journal:  J Neurooncol       Date:  2011-07       Impact factor: 4.130

8.  Towards improving the safety and diagnostic yield of stereotactic biopsy in a single centre.

Authors:  Ruben Dammers; Joost W Schouten; Iain K Haitsma; Arnaud J P E Vincent; Johan M Kros; Clemens M F Dirven
Journal:  Acta Neurochir (Wien)       Date:  2010-08-01       Impact factor: 2.216

9.  [Interdisciplinary neuro-oncology: part 1: diagnostics and operative therapy of primary brain tumors].

Authors:  G Tabatabai; E Hattingen; J Schlegel; W Stummer; U Schlegel
Journal:  Nervenarzt       Date:  2014-08       Impact factor: 1.214

Review 10.  Magnetic resonance spectroscopic imaging in gliomas: clinical diagnosis and radiotherapy planning.

Authors:  Maria Elena Laino; Robert Young; Kathryn Beal; Sofia Haque; Yousef Mazaheri; Giuseppe Corrias; Almir Gv Bitencourt; Sasan Karimi; Sunitha B Thakur
Journal:  BJR Open       Date:  2020-04-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.